Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × lenvatinib × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 31 Cholangiocarcinoma 11 Carcinoma, Renal Cell 6 Stomach Neoplasms 5 Neoplasms 4 Liver Neoplasms 4 Endometrial Neoplasms 3 Biliary Tract Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Kidney Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Vulvar Neoplasms 1 Urogenital Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1

Interventions

Doxorubicin 14 pembrolizumab 9 Gemcitabine 8 Surgical Procedures, Operative 7 Nivolumab 6 Blood Specimen Collection 6 Trabectedin 5 Surveys and Questionnaires 5 Ifosfamide 5 Drug Therapy 5 Cyclophosphamide 5 Radiotherapy 4 Radiation Dose Hypofractionation 4 liposomal doxorubicin 3 fludarabine 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Ipilimumab 3 Docetaxel 3 Biopsy 3 trastuzumab deruxtecan 2 selinexor 2 repotrectinib 2 pazopanib 2 fluzoparib 2 fludarabine phosphate 2 eribulin 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07359053 2026-01-22

MAGNATE-S

Shanghai 6th People's Hospital

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡